These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30143809)

  • 1. [Current treatment of systemic scleroderma].
    Hunzelmann N
    Hautarzt; 2018 Nov; 69(11):901-907. PubMed ID: 30143809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year in review 2020: systemic sclerosis.
    Orlandi M; Lepri G; Damiani A; Barsotti S; Di Battista M; Codullo V; Della Rossa A; Guiducci S; Allanore Y
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):3-17. PubMed ID: 32662404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year in review 2019: systemic sclerosis.
    Barsotti S; Orlandi M; Codullo V; Di Battista M; Lepri G; Della Rossa A; Guiducci S
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):3-14. PubMed ID: 31587697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musculoskeletal Manifestations of Systemic Sclerosis.
    Morrisroe KB; Nikpour M; Proudman SM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):507-18. PubMed ID: 26210132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).
    Valentini G
    Autoimmun Rev; 2015 Mar; 14(3):210-3. PubMed ID: 25461837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
    Distler O; Cozzio A
    Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging targeted therapies in scleroderma lung and skin fibrosis.
    Maurer B; Distler O
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):843-58. PubMed ID: 22265265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current pathophysiological aspects of systemic sclerosis].
    Krieg T; Hunzelmann N
    Z Rheumatol; 2006 Jul; 65(4):275-8. PubMed ID: 16807741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal and extra-renal involvement in sclerodermia].
    Visconti L; Atteritano M; Buemi M; Santoro D
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound in the assessment of musculoskeletal involvement in systemic sclerosis.
    Iagnocco A; Ceccarelli F; Vavala C; Gattamelata A; Scirocco C; Rutigliano IM; Valesini G
    Med Ultrason; 2012 Sep; 14(3):231-4. PubMed ID: 22957329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
    Pellar RE; Pope JE
    Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
    Yanaba K
    J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis of systemic scleroderma.
    Skoumalová A; Horák P; Heřmanová Z; Videman J; Smržová A; Palla V
    Vnitr Lek; 2022; 68(5):285-289. PubMed ID: 36283818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phototherapy in systemic sclerosis: Review.
    Chaowattanapanit S; Choonhakarn C; Foocharoen C; Julanon N
    Photodermatol Photoimmunol Photomed; 2017 Nov; 33(6):296-305. PubMed ID: 28703365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.